Free Trial
NASDAQ:ASBP

Aspire Biopharma (ASBP) Stock Price, News & Analysis

Aspire Biopharma logo
$0.56 +0.02 (+4.47%)
As of 08/28/2025 04:00 PM Eastern

About Aspire Biopharma Stock (NASDAQ:ASBP)

Key Stats

Today's Range
$0.53
$0.58
50-Day Range
$0.24
$0.59
52-Week Range
$0.22
$15.80
Volume
1.76 million shs
Average Volume
27.49 million shs
Market Capitalization
$27.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ASBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspire Biopharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASBP Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
See More Headlines

ASBP Stock Analysis - Frequently Asked Questions

Aspire Biopharma's stock was trading at $0.4301 at the beginning of 2025. Since then, ASBP shares have increased by 29.4% and is now trading at $0.5566.

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) released its quarterly earnings results on Wednesday, August, 13th. The company reported ($0.04) earnings per share for the quarter.

Top institutional investors of Aspire Biopharma include Procyon Advisors LLC (1.31%), Crewe Advisors LLC (1.27%), Optivise Advisory Services LLC (0.47%) and Jane Street Group LLC (0.31%).

Shares of ASBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/13/2025
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ASBP
CIK
1847345
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.54 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-737.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.09
Quick Ratio
0.09

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.19) per share
Price / Book
-2.93

Miscellaneous

Outstanding Shares
49,530,000
Free Float
25,754,000
Market Cap
$27.57 million
Optionable
N/A
Beta
0.79
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:ASBP) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners